...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New SEDAR page

jon, what search did all of what you found fall under on SEDAR+?

I'm having some difficulty navigating it a bit. Thx.

 

Koo

Share
New Message
Please login to post a reply